Cargando…
Topical Ciclopirox Olamine 1%: Revisiting a Unique Antifungal
The injudicious use of antifungals, indiscriminate use of corticosteroids for instant relief, persistence of predisposing factors like sweat retention and uncontrolled diabetes, and emerging resistance to antifungals across the globe have rendered the management of an erstwhile simple infection, the...
Autores principales: | Sonthalia, Sidharth, Agrawal, Mahima, Sehgal, V. N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6615394/ https://www.ncbi.nlm.nih.gov/pubmed/31334080 http://dx.doi.org/10.4103/idoj.IDOJ_29_19 |
Ejemplares similares
-
Superior efficacy of the antifungal agent ciclopirox olamine over gemcitabine in pancreatic cancer models
por: Mihailidou, Chrysovalantou, et al.
Publicado: (2017) -
Aspirin in dermatology: Revisited
por: Bubna, Aditya Kumar
Publicado: (2015) -
3508 Ciclopirox Olamine Demonstrates Inhibitory Effects on Esophageal Tumor Cells
por: Ryan, Randi, et al.
Publicado: (2019) -
Ciclopirox Olamine Induces Proliferation Inhibition and Protective Autophagy in Hepatocellular Carcinoma
por: Wan, Xinyan, et al.
Publicado: (2023) -
Ciclopirox olamine induces ferritinophagy and reduces cyst burden in polycystic kidney disease
por: Radadiya, Priyanka S., et al.
Publicado: (2021)